KR20110036903A - Ｉｑｇａｐ３ 에피토프 펩티드 및 이를 포함하는 백신 - Google Patents

Ｉｑｇａｐ３ 에피토프 펩티드 및 이를 포함하는 백신 Download PDF

Info

Publication number
KR20110036903A
KR20110036903A KR1020117000473A KR20117000473A KR20110036903A KR 20110036903 A KR20110036903 A KR 20110036903A KR 1020117000473 A KR1020117000473 A KR 1020117000473A KR 20117000473 A KR20117000473 A KR 20117000473A KR 20110036903 A KR20110036903 A KR 20110036903A
Authority
KR
South Korea
Prior art keywords
leu
seq
iqgap3
ala
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020117000473A
Other languages
English (en)
Korean (ko)
Inventor
타쿠야 츠노다
류지 오사와
사치코 요시무라
토모히사 와타나베
Original Assignee
온코세라피 사이언스 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 온코세라피 사이언스 가부시키가이샤 filed Critical 온코세라피 사이언스 가부시키가이샤
Publication of KR20110036903A publication Critical patent/KR20110036903A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • C07K14/4706—Guanosine triphosphatase activating protein, GAP
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020117000473A 2008-06-11 2009-06-10 Ｉｑｇａｐ３ 에피토프 펩티드 및 이를 포함하는 백신 Withdrawn KR20110036903A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6053808P 2008-06-11 2008-06-11
US61/060,538 2008-06-11

Publications (1)

Publication Number Publication Date
KR20110036903A true KR20110036903A (ko) 2011-04-12

Family

ID=41416549

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117000473A Withdrawn KR20110036903A (ko) 2008-06-11 2009-06-10 Ｉｑｇａｐ３ 에피토프 펩티드 및 이를 포함하는 백신

Country Status (13)

Country Link
US (1) US20110200626A1 (cg-RX-API-DMAC10.html)
EP (1) EP2303909A4 (cg-RX-API-DMAC10.html)
JP (1) JP2011523937A (cg-RX-API-DMAC10.html)
KR (1) KR20110036903A (cg-RX-API-DMAC10.html)
CN (1) CN102119169A (cg-RX-API-DMAC10.html)
AU (1) AU2009258788A1 (cg-RX-API-DMAC10.html)
BR (1) BRPI0915527A2 (cg-RX-API-DMAC10.html)
CA (1) CA2727485A1 (cg-RX-API-DMAC10.html)
IL (1) IL209869A0 (cg-RX-API-DMAC10.html)
MX (1) MX2010013680A (cg-RX-API-DMAC10.html)
RU (1) RU2010154081A (cg-RX-API-DMAC10.html)
TW (1) TW201000115A (cg-RX-API-DMAC10.html)
WO (1) WO2009150835A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI543767B (zh) 2008-08-19 2016-08-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
TW201134480A (en) * 2010-04-08 2011-10-16 Oncotherapy Science Inc CLUAP1 peptides and vaccines including the same
IL292864A (en) 2015-08-28 2022-07-01 Immatics Biotechnologies Gmbh New peptides and a combination of peptides and supports for use in immunotherapy in certain types of cancer
GB201515321D0 (en) * 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
GB201520542D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
JP6977150B2 (ja) 2017-04-26 2021-12-08 ジーブイエス フィルトレイション，インコーポレイテッド 複合ビードエアフィルタシール
CN112521455B (zh) * 2020-12-08 2022-09-02 长春理工大学 一种检测膀胱癌抗原蛋白特异性的多肽及其应用
CN118930633A (zh) * 2023-05-12 2024-11-12 中国科学院深圳先进技术研究院 肿瘤相关抗原表位肽及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001238347A1 (en) * 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
DE102004026135A1 (de) * 2004-05-25 2006-01-05 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
US7998695B2 (en) * 2005-02-10 2011-08-16 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
EP2305811A1 (en) * 2005-07-27 2011-04-06 Oncotherapy Science, Inc. Method of diagnosing smal cell lung cancer
EP1907582B1 (en) * 2005-07-27 2012-01-04 Oncotherapy Science, Inc. Ect2 as a therapeutic target for esophageal cancer

Also Published As

Publication number Publication date
US20110200626A1 (en) 2011-08-18
TW201000115A (en) 2010-01-01
JP2011523937A (ja) 2011-08-25
EP2303909A4 (en) 2012-10-31
WO2009150835A1 (en) 2009-12-17
IL209869A0 (en) 2011-02-28
BRPI0915527A2 (pt) 2016-01-26
RU2010154081A (ru) 2012-07-20
EP2303909A1 (en) 2011-04-06
CA2727485A1 (en) 2009-12-17
MX2010013680A (es) 2011-02-23
AU2009258788A1 (en) 2009-12-17
CN102119169A (zh) 2011-07-06

Similar Documents

Publication Publication Date Title
US10711047B2 (en) CDCA1 epitope peptides and vaccines containing the same
EP2508601B1 (en) Tem8 peptides and vaccines comprising the same
KR20110063456A (ko) Ｉｎｈｂｂ 에피토프 펩티드 및 이를 포함하는 백신
WO2009150835A1 (en) Iqgap3 epitope peptides and vaccines containing the same
KR20110045052A (ko) Ｈｉｇ２ 및 ｕｒｌｃ１０ 에피토프 펩티드 및 이를 포함하는 백신
WO2009150822A1 (en) Mybl2 epitope peptides and vaccines containing the same
KR101705514B1 (ko) Ｍｅｌｋ 에피토프 펩티드 및 이를 포함하는 백신
WO2010073551A1 (en) C1orf59 peptides and vaccines including the same
KR101705102B1 (ko) Ｗｄｒｐｕｈ 에피토프 펩티드 및 이를 포함하는 백신
WO2010070877A1 (en) Elovl7 epitope peptides and vaccines containing the same
HK1155757A (en) Cdca1 epitope peptides and vaccines containing the same
HK1155757B (en) Cdca1 epitope peptides and vaccines containing the same
HK1175197B (en) Tem8 peptides and vaccines comprising the same

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110107

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid